1. Washington D.C., USA, 22-27 July 2012www.aids2012.org CURE: The point of view of people living with HIV Fred Verdult Amsterdam, The Netherlands Your logo

2. Washington D.C., USA, 22-27 July 2012www.aids2012.org Cure Why a cure would be important for people living with HIV?

3. Washington D.C., USA, 22-27 July 2012www.aids2012.org

4. Washington D.C., USA, 22-27 July 2012www.aids2012.org

5. Washington D.C., USA, 22-27 July 2012www.aids2012.org

6. Washington D.C., USA, 22-27 July 2012www.aids2012.org

7. Washington D.C., USA, 22-27 July 2012www.aids2012.org

8. Washington D.C., USA, 22-27 July 2012www.aids2012.org Why is a cure important?

9. Washington D.C., USA, 22-27 July 2012www.aids2012.org Why is a cure important? The answers of Steven Deeks:

10. Washington D.C., USA, 22-27 July 2012www.aids2012.org Why is a cure important? The answers of Steven Deeks: Life expectancy

11. Washington D.C., USA, 22-27 July 2012www.aids2012.org Why is a cure important? The answers of Steven Deeks: Life expectancy Long term side effects

12. Washington D.C., USA, 22-27 July 2012www.aids2012.org Why is a cure important? The answers of Steven Deeks: Life expectancy Long term side effects Financial reasons

13. Washington D.C., USA, 22-27 July 2012www.aids2012.org

14. Washington D.C., USA, 22-27 July 2012www.aids2012.org

15. Washington D.C., USA, 22-27 July 2012www.aids2012.org

16. Washington D.C., USA, 22-27 July 2012www.aids2012.org Dan Kuritzkes:

17. Washington D.C., USA, 22-27 July 2012www.aids2012.org Dan Kuritzkes: “When can we start a trial with patients?”

18. Washington D.C., USA, 22-27 July 2012www.aids2012.org Research questions

19. Washington D.C., USA, 22-27 July 2012www.aids2012.org Research questions From the PERSPECTIVE of people living with HIV:

20. Washington D.C., USA, 22-27 July 2012www.aids2012.org Research questions From the PERSPECTIVE of people living with HIV: How important is a cure? WHY?

21. Washington D.C., USA, 22-27 July 2012www.aids2012.org Research questions From the PERSPECTIVE of people living with HIV: How important is a cure? WHY? WHICH cure is preferred?

22. Washington D.C., USA, 22-27 July 2012www.aids2012.org Respondents

23. Washington D.C., USA, 22-27 July 2012www.aids2012.org Database of 1,002 names contacted Respondents

24. Washington D.C., USA, 22-27 July 2012www.aids2012.org Database of 1,002 names contacted Response: 458 (= 46%) Respondents

25. Washington D.C., USA, 22-27 July 2012www.aids2012.org Database of 1,002 names contacted Response: 458 (= 46%) May 15–31 (+ 4 respondents in June) Respondents

26. Washington D.C., USA, 22-27 July 2012www.aids2012.org

27. Washington D.C., USA, 22-27 July 2012www.aids2012.org

28. Washington D.C., USA, 22-27 July 2012www.aids2012.org

29. Washington D.C., USA, 22-27 July 2012www.aids2012.org

30. Washington D.C., USA, 22-27 July 2012www.aids2012.org

31. Washington D.C., USA, 22-27 July 2012www.aids2012.org

32. Washington D.C., USA, 22-27 July 2012www.aids2012.org

33. Washington D.C., USA, 22-27 July 2012www.aids2012.org

34. Washington D.C., USA, 22-27 July 2012www.aids2012.org

35. Washington D.C., USA, 22-27 July 2012www.aids2012.org

36. Washington D.C., USA, 22-27 July 2012www.aids2012.org

37. Washington D.C., USA, 22-27 July 2012www.aids2012.org

38. Washington D.C., USA, 22-27 July 2012www.aids2012.org

39. Washington D.C., USA, 22-27 July 2012www.aids2012.org

40. Washington D.C., USA, 22-27 July 2012www.aids2012.org

41. Washington D.C., USA, 22-27 July 2012www.aids2012.org

42. Washington D.C., USA, 22-27 July 2012www.aids2012.org

43. Washington D.C., USA, 22-27 July 2012www.aids2012.org

44. Washington D.C., USA, 22-27 July 2012www.aids2012.org

45. Washington D.C., USA, 22-27 July 2012www.aids2012.org “No longer having that feeling of uncertainty” Uncertainty

46. Washington D.C., USA, 22-27 July 2012www.aids2012.org “No longer having that feeling of uncertainty” “Having less anxiety about the future” Uncertainty

47. Washington D.C., USA, 22-27 July 2012www.aids2012.org

48. Washington D.C., USA, 22-27 July 2012www.aids2012.org

49. Washington D.C., USA, 22-27 July 2012www.aids2012.org

50. Washington D.C., USA, 22-27 July 2012www.aids2012.org

51. Washington D.C., USA, 22-27 July 2012www.aids2012.org “No longer being afraid of infecting others” Risk of infecting

52. Washington D.C., USA, 22-27 July 2012www.aids2012.org

53. Washington D.C., USA, 22-27 July 2012www.aids2012.org

54. Washington D.C., USA, 22-27 July 2012www.aids2012.org “Not having to deal with the stigma anymore” Stigma

55. Washington D.C., USA, 22-27 July 2012www.aids2012.org

56. Washington D.C., USA, 22-27 July 2012www.aids2012.org

57. Washington D.C., USA, 22-27 July 2012www.aids2012.org

58. Washington D.C., USA, 22-27 July 2012www.aids2012.org

59. Washington D.C., USA, 22-27 July 2012www.aids2012.org

60. Washington D.C., USA, 22-27 July 2012www.aids2012.org Gggggg Ggg Gggh H O Gggggg Ggg Gggh H O

61. Washington D.C., USA, 22-27 July 2012www.aids2012.org Gggggg Ggg Gggh H O

62. Washington D.C., USA, 22-27 July 2012www.aids2012.org Gggggg Ggg Gggh H O

63. Washington D.C., USA, 22-27 July 2012www.aids2012.org

64. Washington D.C., USA, 22-27 July 2012www.aids2012.org Gggggg Ggg Gggh H O

65. Washington D.C., USA, 22-27 July 2012www.aids2012.org

66. Washington D.C., USA, 22-27 July 2012www.aids2012.org Gggggg Ggg Gggh H O

67. Washington D.C., USA, 22-27 July 2012www.aids2012.org

68. Washington D.C., USA, 22-27 July 2012www.aids2012.org

69. Washington D.C., USA, 22-27 July 2012www.aids2012.org Follow-up study Multinational study to characterize the willingness of people living with HIV to participate in cure trials

70. Washington D.C., USA, 22-27 July 2012www.aids2012.org Meeting on July 23, including: Michael Arnold, USA Françoise Barré-Sinoussi, FR Steven Deeks, USA Matthias Eggert, SW David Evans, USA Sophie Gravat, FR Richard Jefferys, USA Dan Kuritzkes, USA Joep Lange, NL Peter Newman, CA Veronica Noseda, FR Bruno Spire, FR Marie Suzan, FR Nelson Vergel, USA Fred Verdult, NL

71. Washington D.C., USA, 22-27 July 2012www.aids2012.org

72. Washington D.C., USA, 22-27 July 2012www.aids2012.org